Join Christopher Habig in an enlightening conversation with Dr. Mark Dybul, CEO of Renovaro Biosciences and professor of medicine at Georgetown University Medical Center. The episode explores the challenges of healthcare innovation, advocating for a departure from bureaucratic hospital systems. Dr. Dybul shares Renovaro Biosciences' groundbreaking approach to cancer treatment, emphasizing immune system retraining and genetic modifications to minimize reliance on traditional chemotherapy. The discussion highlights the vision of democratizing access to innovative healthcare solutions, empowering providers in real-time decision-making, and fostering a culture of experimentation. As the episode concludes, Dr. Dybul offers invaluable advice for aspiring medical professionals: think big, push boundaries, and embrace technology to overcome challenges and drive innovation.More on Freedom Healthworks & FreedomDocSubscribe at https://healthcareamericana.com/episodes/More on Dr. Mark Dybul & Renovaro BiosciencesFollow Healthcare Americana:Instagram & LinkedIN